NAT Diagnostics Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 2

Employees

  • Latest Deal Type
  • M&A

NAT Diagnostics General Information

Description

Developer of a molecular diagnostic platform designed to provide true Point-of-Care testing for infectious diseases. The company's platform uses a technology that is based on a novel isothermal nucleic acid amplification and detection method that requires only ten minutes, enabling physicians' offices, clinics and pharmacies to offer Point-of-Care testing results that are highly accurate and costs low.

Contact Information

Website
www.natdx.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 11585 Sorrento Valley Road
  • Suite 107
  • San Diego, CA 92121
  • United States
Primary Industry
Decision/Risk Analysis
Vertical(s)
Corporate Office
  • 11585 Sorrento Valley Road
  • Suite 107
  • San Diego, CA 92121
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

NAT Diagnostics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 15-May-2020 00.000 Completed Generating Revenue
2. Seed Round 16-Nov-2017 00.00 00.000 Completed Startup
1. Seed Round 11-Sep-2015 $2.91M $2.91M Completed Startup
To view NAT Diagnostics’s complete valuation and funding history, request access »

NAT Diagnostics Patents

NAT Diagnostics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-11118219-B2 Isothermal amplification components and processes Active 04-Apr-2016 0000000000 00
US-11299777-B2 Isothermal amplification components and processes Active 04-Apr-2016 0000000000 00
US-20200332340-A1 Isothermal amplification components and processes Active 04-Apr-2016 0000000000
ES-2881509-T3 Isothermal amplification components and procedures Active 04-Apr-2016 0000000000
US-20220251629-A1 Isothermal amplification components and processes Pending 04-Apr-2016 C12Q1/6844
To view NAT Diagnostics’s complete patent history, request access »

NAT Diagnostics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

NAT Diagnostics FAQs

  • When was NAT Diagnostics founded?

    NAT Diagnostics was founded in 2014.

  • Who is the founder of NAT Diagnostics?

    Andrew Miller Ph.D is the founder of NAT Diagnostics.

  • Where is NAT Diagnostics headquartered?

    NAT Diagnostics is headquartered in San Diego, CA.

  • What is the size of NAT Diagnostics?

    NAT Diagnostics has 2 total employees.

  • What industry is NAT Diagnostics in?

    NAT Diagnostics’s primary industry is Decision/Risk Analysis.

  • Is NAT Diagnostics a private or public company?

    NAT Diagnostics is a Private company.

  • What is NAT Diagnostics’s current revenue?

    The current revenue for NAT Diagnostics is 000000.

  • How much funding has NAT Diagnostics raised over time?

    NAT Diagnostics has raised $4.41M.

  • When was NAT Diagnostics acquired?

    NAT Diagnostics was acquired on 15-May-2020.

  • Who acquired NAT Diagnostics?

    NAT Diagnostics was acquired by Becton, Dickinson and Company.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »